Cancer patients with incidental VTE have high risk of recurrent thrombiDecember 9, 2014Patient & Survivor CareThrombosis
Molecular monitoring and minimal residual disease in the management of chronic myelogenous leukemiaMay 27, 2014Patient & Survivor CareCML
